Earnings Per Share

EPS (Basic, Discontinued)

Over 4 years (FY 2021 to FY 2025), EPS (Basic, Discontinued) shows an upward trend with a -100.0% CAGR.

Analysis

StatementIncome Statement
SectionEarnings Per Share
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026

How to read this metric

Positive values indicate gains from divestitures, while negative values indicate losses from exiting business lines.

Detailed definition

This represents the earnings or losses per basic share attributable to business segments that have been sold, shut down,...

Peer comparison

Standard reporting requirement for companies undergoing restructuring or divestitures.

Metric ID: eps_basic_discontinued

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value-$0.04$0.00-$0.04$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
QoQ Change+100.0%+100.0%-100.0%
YoY Change+125.0%+100.0%-100.0%
Range-$0.04$0.01
CAGR-100.0%
Avg YoY Growth+41.7%
Median YoY Growth+100.0%

Frequently Asked Questions

What is Pfizer's eps (basic, discontinued)?
Pfizer (PFE) reported eps (basic, discontinued) of $0.00 in Q1 2026.
What is the long-term trend for Pfizer's eps (basic, discontinued)?
Over 4 years (2021 to 2025), Pfizer's eps (basic, discontinued) has grown at a -100.0% compound annual growth rate (CAGR), from $-0.08 to $0.00.
What does eps (basic, discontinued) mean?
The profit or loss per share generated by business units that are no longer part of the company's core operations.